{"database": "lobbying", "table": "lobbying_activities", "rows": [[2111710, "776f96f7-e6a2-4b44-bbcb-e0444efe0063", "Q1", "HANCE SCARBOROUGH", 17443, "TITAN PHARMACEUTICALS, INC.", 2018, "first_quarter", "MMM", "Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2018-04-18T16:18:37.537000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2111710"], "units": {}, "query_ms": 0.33940200228244066, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}